Dr Reddy's Laboratories (RDY) Stock Price, Quote, News & History

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

Volume / Avg.

81.00 / 1.08M

Day Range

- - -

52 Wk Range

12.26 - 16.17

Market Cap

$11.67B

P/E Ratio

17.91

Dividend Yield

0.65%

Exchange

NYSE

RSI

Short Interest

2.15%

Days to Cover

9.22

Recent Dr Reddy's Laboratories Ltd News

FDA Weighs Rapid Review For Eli Lilly Obesity Pill As Novo Nordisk Nears Launch

FDA may expedite approval timeline for Eli Lilly's weight-loss treatment, potentially moving decision date to late March from May.

Vandana Singh

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs

The Trump administration backs off plans to impose tariffs on generic drugs after internal debate over price impacts and supply concerns.

Vandana Singh

Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug

Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

Volume / Avg.

81.00 / 1.08M

Day Range

- - -

52 Wk Range

12.26 - 16.17

Market Cap

$11.67B

P/E Ratio

17.91

Dividend Yield

0.65%

Exchange

NYSE

RSI

Short Interest

2.15%

Days to Cover

9.22

About

Sector

Health Care

Industry

Pharmaceuticals

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry